Tue, Sep 23, 2014, 5:03 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Novadaq Technologies Inc. Message Board

  • e11ndofwar e11ndofwar Dec 12, 2012 8:24 AM Flag

    short interest

    Here is one explanation for the pps errosion we have recently experienced. As indicated by the following there has been a very steady increase in short interest.
    9/28 65,000 shares short
    10/15 258,000
    10/31 448,000
    11/15 768,000
    11/30 1,104,000
    Any thoughts?
    regards endo

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • kkllfla@bellsouth.net kkllfla Dec 14, 2012 8:52 AM Flag

      As U know, shorts have had their way with numerous biotech startups (amrn,vvus,arna...) so this should not be very different. EXCEPT...NVDQ appears to have a real and expanding application base for this unique technology. If they continue to succeed with their application results, this could expand to a very broad range of diagnostic & operational uses. Just the thought of being able, in real time, for a surgeon to know exactly when to stop excising tissue, or identify the exact edge of any invasive tumor or growth in the body is amazing. And vascular usage is still developing.

      Sentiment: Buy

    • andersongordon@ymail.com andersongordon Dec 12, 2012 11:00 AM Flag

      If they come in close to breakeven in earnings (50-50 likelyhood), and there is positive conversations in the conference call about pinpoint, there will be a short squeeze---possibly to $13 range.

      GSA

      Sentiment: Strong Buy

    • Yep, dont get your **** caught in the door

 
NVDQ
12.75+0.08(+0.63%)Sep 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.